Additionally, elevated leptin, resistin, and chemerin concentrations are common in NAFLD patients that also play a crucial role in the aggravation of NAFLD and the development of coronary atherosclerosis, and the potential mechanisms are described below (116, 117). The gene discussed is LEP; the disease is metabolic dysfunction-associated steatotic liver disease.